Atlas FDA

Predicate Research Report · generated 2026-08-22 · Print / save as PDF · Save to account

Euro-Diagnostica AB — Predicate Candidate Screening

6 FDA 510(k) clearances under this manufacturer; the 50 most recent screened below.

175 daysmedian FDA review time
344 days90th percentile
6clearances measured
K-numberDeviceApplicantDecidedReview daysRecalls (K-match)
K093908CCPOINTEuro-Diagnostica AB2010-12-013440
K091657IMMUNOSCAN CCPLUSEuro-Diagnostica AB2009-11-191631
K062045EDIA ANTI-CCPEuro-Diagnostica AB2006-12-041380
K971690IMMUNOSCAN PR3-ANCAEuro-Diagnostica AB1997-10-291750
K971464IMMUNOSCAN ANTI-GBM QUANTITATIVE KITEuro-Diagnostica AB1997-10-291900
K971689IMMUNOSCAN ANTI-MYELOPEROXIDASE ANTIBODIES (MPO-ANCA) QUANTIEuro-Diagnostica AB1997-10-291750

Methodology

Recall counts reflect FDA recall records explicitly referencing each K-number; FDA links recalls to K-numbers inconsistently, so 0 means "none found in FDA records," not "never recalled." Data: FDA openFDA, refreshed weekly. Verify decisions of consequence against the primary source. Full candidate set and CSV export: atlasbyauro.com.

Prepared with Atlas

Predicate research, review-time statistics and recall monitoring for 510(k) teams — atlasbyauro.com/fda